Hopp til hovedinnhold

Hjertestarter, implanterbar

En implanterbar hjertestarter, en defibrillator, virker ved å oppdage og stanse farlige, unormale hjerterytmer (arytmier). Hjertestarteren overvåker hjerteslagene hele tiden, og den avgir elektriske sjokk for å gjenopprette normal hjerterytme om nødvendig.

Sist revidert:

QR
Del pasientinformasjon

Den ligger åpent tilgjengelig på NHI.no sammen annen relevant informasjon

https://nhi.no/sykdommer/hjertekar/hjertearytmier/hjertestarter-implanterbar/ 

Hva er en implanterbar hjertestarter?

Hvorfor implanteres en hjertestarter?

Hvordan fungerer hjertet?

Hvordan virker hjertestarteren?

Hvem behøver en implanterbar hjertestarter?

Er implantasjonen forbundet med noen risiko?

Hvordan avgjør man om du trenger hjertestarter?

Selve operasjonen

Hva gjør du om du får et støt?

Hjertestarteren må kontrolleres

Er hjertestarteren til nytte?

Hvordan kan jeg leve med en implantert hjertestarter?

Hva med bilkjøring?

Vil du vite mer?

Kilder

Referanser

Dette dokumentet er basert på det profesjonelle dokumentet Hjertedefibrillator, implanterbar. Referanselisten for dette dokumentet vises nedenfor.

  1. Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 2013; 10: 1932-63. pmid:24011539 PubMed 
  2. Katritsis DG, Gersh BJ, Camm AJ. A Clinical Perspective on Sudden Cardiac Death. Arrhythm Electrophysiol Rev 2016; 5: 177-82. pmid:28116082 PubMed 
  3. Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980; 303:322. New England Journal of Medicine 
  4. Risgaard B, Winkel BG, Jabbari R, et al. Burden of sudden cardiac death in persons aged 1 to 49 years: Nationwide study in Denmark. Circ Arrhythm Electrophysiol. 2014;7:205–211. PMID: 24604905 PubMed 
  5. Berdowski J, de Beus MF, Blom M, et al. Exercise-related out-of-hospital cardiac arrest in the general population: incidence and prognosis. Eur Heart J. 2013;34:3616–3623. PMID: 24096330 PubMed 
  6. Mozaffarian D, Benjamin EJ, Go AS et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics – 2015 update: A report from the American Heart Association. Circulation. 2015;131 e29–322. PMID: 25520374 PubMed 
  7. Myerburg RJ, Junttila MJ. Sudden Cardiac Death Caused by Coronary Heart Disease. Circulation 2012; 125: 1043-52. pmid:22371442 PubMed 
  8. Harmon KG, Asif IM, Maleszewski JJ, et al. Incidence and Etiology of Sudden Cardiac Arrest and Death in High School Athletes in the United States. Mayo Clin Proc 2016; 91: 1493-502. pmid:27692971 PubMed 
  9. Hookana E, Junttila MJ, Puurunen VP, et al. Causes of nonischemic sudden cardiac death in the current era. Heart Rhythm 2011; 8: 1570-5. pmid:21740887 PubMed 
  10. Curtis JP, Luebbert JJ, Wang Y, et al. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA 2009; 301: 1661-70. Journal of the American Medical Association 
  11. Zipes DP, Roberts D. Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators. Circulation 1995; 92: 59-65. Circulation 
  12. Epstein AE, DiMarco JP, Ellenbogen KA, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 2013; 127: 283-352. pmid:23255456 PubMed 
  13. Ramalho D, Freitas J. Drug-induced life-threatening arrhythmias and sudden cardiac death: A clinical perspective of long QT, short QT and Brugada syndromes. Rev Port Cardiol. 2018; 37: 435-46. pmid:29636202 PubMed 
  14. Myerburg RJ. Implantable cardioverter-defibrillators after myocardial infarction. N Engl J Med 2008; 359: 2245-53. New England Journal of Medicine 
  15. DiMarco JP. Implantable cardioverter-defibrillators. N Engl J Med 2003; 349:1836. New England Journal of Medicine 
  16. Connolly SJ, Gent M, Roberts RS, et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000; 101: 1297-1302. Circulation 
  17. Gehi AK, Mehta D, Gomes JA. Evaluation and management of patients after implantable cardioverter-defibrillator shock. JAMA 2006; 296: 2839-47. Journal of the American Medical Association 
  18. Germano JJ, Reynolds M, Essebag V, Josephson ME. Frequency and causes of implantable cardioverterdefibrillator therapies: is device therapy proarrhythmic? Am J Cardiol 2006; 97: 1255-61. PubMed 
  19. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e385–e484.
  20. Maisel WH, Hauser RG, Hammill SC, et al. Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines: developed in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Heart Rhythm 2009; 6: 869-85. PubMed 
  21. Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 2013; 34: 2281-329. pmid:24774265 PubMed